FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159793423> ?p ?o ?g. }

• W3159793423 abstract "BAD (Bcl-2 antagonist of cell death, Bcl-2 associated death promoter) is a pro-apoptotic member of the Bcl-2 protein family that is regulated by phosphorylation in response to survival factors. Although much attention has been devoted to the identification of phosphorylation sites in murine BAD (mBAD), little data are available with respect to phosphorylation of human BAD (hBAD) protein. In this work, we investigated the quantitative contribution of BAD targeting kinases in phosphorylating serines 75, 99 and 118 of hBAD (Chapter 3.1). Our results indicate that RAF kinases phosphorylate hBAD in vivo at these established serine residues. RAF-induced phosphorylation of hBAD was not prevented by MEK inhibitors but could be reduced to control levels by use of the RAF inhibitor Sorafenib (BAY 43-9006). Consistently, expression of active RAF suppressed apoptosis induced by hBAD and the inhibition of colony formation caused by hBAD could be prevented by RAF. In addition, using surface plasmon resonance technique we analyzed the direct consequences of hBAD phosphorylation by RAF with respect to complex formation of BAD with 14-3-3 proteins and Bcl-XL. Phosphorylation of hBAD by active RAF promotes 14-3-3 protein association, whereby the phosphoserine 99 represents the major binding site. Furthermore, we demonstrate in this work that hBAD forms channels in planar bilayer membranes in vitro. This pore-forming capacity is dependent on phosphorylation status and interaction with 14-3-3 proteins. Additionally, we show that hBAD pores possess a funnel-shaped geometry that can be entered by ions and non-charged molecules up to 200 Da (Chapter 3.2). Since both lipid binding domains of hBAD (LBD1 and LBD2) are located within the C-terminal region, we investigated this part of the protein with respect to its structural properties (Chapter 3.3). Our results demonstrate that the C-terminus of hBAD possesses an ordered β-sheet structure in aqueous solution that adopts helical disposition upon interaction with lipid membranes. Additionally, we show that the interaction of the C-terminal segment of hBAD with the BH3 domain results in the formation of permanently open pores, whereby the phosphorylation of serine 118 proved to be necessary for effective pore-formation. In contrast, phosphorylation of serine 99 in combination with 14-3-3 association suppresses formation of channels. These results indicate that the C-terminal part of hBAD controls hBAD function by structural transitions, lipid binding and phosphorylation. Using mass spectrometry we identified in this work, besides the established in vivo phosphorylation sites at serines 75, 99 and 118, several novel hBAD phosphorylation sites (serines 25, 32/34, 97, 124 and 134, Chapter 3.1). To further analyze the regulation of hBAD function, we investigated the role of these newly identified phosphorylation sites on BAD-mediated apoptosis. We found that in contrast to the N-terminal phosphorylation sites, the C-terminal serines 124 and 134 act in an anti-apoptotic manner (Chapter 3.4). Our results further indicate that RAF kinases and PAK1 effectively phosphorylate BAD at serine 134. Notably, in the presence of wild type hBAD, co-expression of survival kinases, such as RAF and PAK1, leads to a strongly increased proliferation, whereas substitution of serine 134 by alanine abolishes this process. Furthermore, we identified hBAD serine 134 to be strongly involved in survival signaling in B-RAF-V600E containing tumor cells and found phosphorylation of this residue to be crucial for efficient proliferation in these cells. Collectively, our findings provide new insights into the regulation of hBAD function by phosphorylation and its role in cancer signaling." @default.
• W3159793423 created "2021-05-10" @default.
• W3159793423 creator A5069468212 @default.
• W3159793423 date "2011-01-01" @default.
• W3159793423 modified "2023-09-23" @default.
• W3159793423 title "BAD Phosphorylation: A Novel Link between Apoptosis and Cancer" @default.
• W3159793423 cites W134223655 @default.
• W3159793423 cites W1490240498 @default.
• W3159793423 cites W1509340652 @default.
• W3159793423 cites W1528039142 @default.
• W3159793423 cites W1532194993 @default.
• W3159793423 cites W1550706623 @default.
• W3159793423 cites W1554372630 @default.
• W3159793423 cites W1557686543 @default.
• W3159793423 cites W1564861448 @default.
• W3159793423 cites W1566777539 @default.
• W3159793423 cites W1593219141 @default.
• W3159793423 cites W1607777232 @default.
• W3159793423 cites W1611419331 @default.
• W3159793423 cites W1637493245 @default.
• W3159793423 cites W1671937407 @default.
• W3159793423 cites W1693710877 @default.
• W3159793423 cites W1758051434 @default.
• W3159793423 cites W1819015028 @default.
• W3159793423 cites W1826874877 @default.
• W3159793423 cites W1870720170 @default.
• W3159793423 cites W1893019349 @default.
• W3159793423 cites W190488077 @default.
• W3159793423 cites W1913661233 @default.
• W3159793423 cites W1928407971 @default.
• W3159793423 cites W1948126359 @default.
• W3159793423 cites W1954929088 @default.
• W3159793423 cites W1958258471 @default.
• W3159793423 cites W1963809300 @default.
• W3159793423 cites W1964313477 @default.
• W3159793423 cites W1964343070 @default.
• W3159793423 cites W1964617786 @default.
• W3159793423 cites W1965217295 @default.
• W3159793423 cites W1965286700 @default.
• W3159793423 cites W1965343041 @default.
• W3159793423 cites W1965575645 @default.
• W3159793423 cites W1966398434 @default.
• W3159793423 cites W1966809971 @default.
• W3159793423 cites W1967828766 @default.
• W3159793423 cites W1967835627 @default.
• W3159793423 cites W1967861082 @default.
• W3159793423 cites W1967972955 @default.
• W3159793423 cites W1968142651 @default.
• W3159793423 cites W1968574801 @default.
• W3159793423 cites W1972279573 @default.
• W3159793423 cites W1972580962 @default.
• W3159793423 cites W1974564127 @default.
• W3159793423 cites W1974646396 @default.
• W3159793423 cites W1975131304 @default.
• W3159793423 cites W1975857526 @default.
• W3159793423 cites W1976676780 @default.
• W3159793423 cites W1976720365 @default.
• W3159793423 cites W1977258127 @default.
• W3159793423 cites W1978974783 @default.
• W3159793423 cites W1979331393 @default.
• W3159793423 cites W1980254337 @default.
• W3159793423 cites W1980792888 @default.
• W3159793423 cites W1981166298 @default.
• W3159793423 cites W1982459028 @default.
• W3159793423 cites W1983398917 @default.
• W3159793423 cites W1983771987 @default.
• W3159793423 cites W1985035689 @default.
• W3159793423 cites W1985309852 @default.
• W3159793423 cites W1986199954 @default.
• W3159793423 cites W1987035130 @default.
• W3159793423 cites W1987821958 @default.
• W3159793423 cites W1987836616 @default.
• W3159793423 cites W1988901585 @default.
• W3159793423 cites W1989052616 @default.
• W3159793423 cites W1989220379 @default.
• W3159793423 cites W1990239056 @default.
• W3159793423 cites W1990408342 @default.
• W3159793423 cites W1990863976 @default.
• W3159793423 cites W1991226544 @default.
• W3159793423 cites W1992838895 @default.
• W3159793423 cites W1992843538 @default.
• W3159793423 cites W1993059855 @default.
• W3159793423 cites W1995338261 @default.
• W3159793423 cites W1996372785 @default.
• W3159793423 cites W1997533142 @default.
• W3159793423 cites W1998198750 @default.
• W3159793423 cites W1998595310 @default.
• W3159793423 cites W2000056018 @default.
• W3159793423 cites W2000446104 @default.
• W3159793423 cites W2000681550 @default.
• W3159793423 cites W2001068860 @default.
• W3159793423 cites W2001543531 @default.
• W3159793423 cites W2002167625 @default.
• W3159793423 cites W2002716364 @default.
• W3159793423 cites W2002919668 @default.
• W3159793423 cites W2003388311 @default.
• W3159793423 cites W2003472250 @default.
• W3159793423 cites W2004295816 @default.
• W3159793423 cites W2005532023 @default.
• W3159793423 cites W2005909927 @default.

• next